AMY MARTINDALE: Open Payments
NPI 1851769863 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,882 in 154 payments from 18 companies in 2025. Trend: 2023 $2,246 · 2024 $2,839 · 2025 $2,882
Food & beverage: $2,882
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $894 |
| Janssen Biotech, Inc. | 19 | $282 |
| Madrigal Pharmaceuticals | 7 | $223 |
| Phathom Pharmaceuticals, Inc. | 15 | $177 |
| GENZYME CORPORATION | 10 | $165 |
| Ipsen Biopharmaceuticals, Inc | 9 | $164 |
| Pharmacosmos Therapeutics Inc. | 1 | $148 |
| Novo Nordisk Inc | 2 | $142 |
| Regeneron Healthcare Solutions, Inc. | 5 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $107 |
Products named: RINVOQ, DUPIXENT, TREMFYA, LINZESS, REZDIFFRA, VOQUEZNA, IQIRVO, MONOFERRIC.
Industry payments across OK — which companies pay providers there.
